Heavy Menstrual Bleeding and Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University

NCT07852143 | Not Yet Recruiting

• 1 other identifier: HMB and Dysmenorrhea in Assiut
• Study Type: observational
• Target: 486
• Locations: 0 countries
• Sites: N/A

Brief Summary

Menstrual disorders, particularly dysmenorrhea (painful menstruation) and heavy menstrual bleeding (excessive menstrual blood loss), are common conditions among young adult females that can substantially impact quality of life, university attendance, and academic performance. This study aims to evaluate the prevalence of heavy menstrual bleeding and determine the intensity of dysmenorrhea among undergraduate female medical students at Assiut University. Participants in this cross-sectional observational study include nulliparous and nulligravid female undergraduate students enrolled in the Faculty of Medicine. Data collection involves face-to-face interviews and self-completed assessment instruments during non-instructional hours. Dysmenorrhea severity, pain characteristics, and related functional impairment are evaluated using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. Menstrual blood volume is quantified using the Pictorial Blood Loss Assessment Chart (PBLAC) during the menstrual period to identify heavy menstrual bleeding. Additionally, the study assesses associated physical symptoms, academic absenteeism, and common pharmacological and non-pharmacological management strategies utilized by the participants.

Conditions

Dysmenorrhea; Menorrhagia; Heavy Menstrual Bleeding

Keywords

WaLIDD Score; Pictorial Blood Loss Assessment Chart; PBLAC; Primary Dysmenorrhea; Menstrual Disorders; Absenteeism; Medical Students

Outcome Measures

Primary Outcomes (1)

• Dysmenorrhea Severity Assessed by the WaLIDD Score

  Assessed using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. The instrument evaluates 4 domains: study/work ability (0 to 3), anatomical pain locations (0 to 3), pain intensity (0 to 3), and duration of pain in days (0 to 3). The total score ranges from 0 to 12 points, categorized as follows: 0 indicates no dysmenorrhea, 1 to 4 indicates mild dysmenorrhea, 5 to 7 indicates moderate dysmenorrhea, and 8 to 12 indicates severe dysmenorrhea. Higher scores reflect greater symptom severity and functional impairment.

  Baseline

Study Arms (1)

Female Undergraduate Medical Students

Nulliparous and nulligravid undergraduate female students enrolled in the Faculty of Medicine at Assiut University. Participants complete an adapted semi-structured questionnaire incorporating the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) scale to assess dysmenorrhea severity, associated symptoms, academic impact, and management practices. In addition, participants evaluate menstrual blood loss during their menstrual cycle using the Pictorial Blood Loss Assessment Chart (PBLAC) to determine the prevalence of heavy menstrual bleeding. No therapeutic or experimental intervention is administered.

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Undergraduate female medical students enrolled in the Faculty of Medicine at Assiut University, Assiut, Egypt. Eligible participants are nulliparous and nulligravid female students recruited on campus during non-learning hours to complete face-to-face interviews and menstrual symptom assessments.

You may qualify if:

• Undergraduate female students enrolled in the Faculty of Medicine, Assiut University
• Nulliparous and nulligravid females

You may not qualify if:

• History of previous pregnancy or childbirth (currently gravid or parous females)
• Students enrolled in non-medical faculties or postgraduate academic programs
• Refusal or inability to complete the interview questionnaire or the Pictorial Blood Loss Assessment Chart (PBLAC)

Sponsors & Collaborators

• Assiut University: lead

MeSH Terms

Conditions

Dysmenorrhea; Menorrhagia; Menstruation Disturbances

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pelvic Pain; Pain; Neurologic Manifestations; Signs and Symptoms; Uterine Hemorrhage; Uterine Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases; Hemorrhage

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident

Study Record Dates

• First Submitted: September 25, 2026
• First Posted: October 1, 2026
• Study Start: October 1, 2026
• Primary Completion (Estimated): October 1, 2027
• Study Completion (Estimated): November 1, 2027
• Last Updated: October 1, 2026

Record last verified: 2026-09